High-risk genotype for type 1 diabetes: A new simple microtiter plate-based ELOSA assay

Genetic Testing

Volumn 7, Issue 1, 2003, Pages 7-12

  Geranton, S ^c   Rostagnat Stefanutti, A ^a   Bendelac, N ^b   Cerrato, E ^c   Barbalat, V ^c   Leissner, P ^c   Nicolino, M ^b   Thivolet, C ^a   Mougin, B ^c  

^a INSERM   (France)

^b HÔPITAL DEBROUSSE   (France)

^c BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HORSERADISH PEROXIDASE; OLIGONUCLEOTIDE; PEROXIDASE;

ALLELE; ARTICLE; BLOOD SAMPLING; COLORIMETRY; CORRELATION ANALYSIS; DNA EXTRACTION; DNA HYBRIDIZATION; ENZYME SUBSTRATE; EXON; FRANCE; GENE PROBE; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MICROTITER PLATE ASSAY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TECHNIQUE;

ALLELES; COLORIMETRY; DIABETES MELLITUS, TYPE 1; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

ARMORACIA RUSTICANA; ELOSA;

EID: 0037357691     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703321560877     Document Type: Article

References (23)

1. AMERICAN DIABETES ASSOCIATION. (1997). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
2. BECKER, K.G. (1999). Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways. Diabetes 48, 1353-1358.
3. BINGLEY, P.J., CHRISTIE, M.R., BONIFACIO, E., et al. (1994). Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43, 1304-1310.
4. CINEK, O., WILKINSON, E., PALTIEL, L., et al. (2000). Screening for the IDDM high-risk genotype. A rapid microtiter plate method using serum as source of DNA. Tissue Antigens 56, 344-349.
5. COHEN-HAGUENAUER, O., ROBBINS, E., MASSART, C., et al. (1985). A systemic study of HLA class II-b DNA restriction fragments in insulin dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 82, 3335-3339.
6. CROS, P., ALLIBERT, P., MANDRAND, B., et al. (1992). Oligonucleotide genotyping of HLA polymorphism on microtiter plate. Lancet 340, 873-876.
7. GU, X.F., LARGER, E., CLAUSER, E., et al. (1991). HLA-DQA1 and DQB1 alleles in French and Algerian type 1 diabetic subjects. Diabetes Res. 17, 189-197.
8. HEZARD, N., CORNILLET, P., DROULLE, C., et al. (1997). Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate position. Thromb. Res. 88, 59-66.
9. ILONEN, J., REIJONEN, H., HERVA, E., et al. (1996). Rapid HLA-DQB 1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 19, 795-800.
10. ILONEN, J., REIJONEN, H., GREEN, A., et al. (2000). Geographical differences within Finland in the frequency of HLA-DQ genotypes associated with Type 1 diabetes susceptibility. J. Immunogenet. 27, 225-230.
11. IMAGAWA, A., HANAFUSA, T., MIYAGAWA, J., et al. (2000). A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N. Engl. J. Med. 342, 301-307.
12. JINKS, D.C., MINTER, M., TARVER, D.A., et al. (1989). Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum. Genet. 81, 363-366.
13. KIMPIMAKI, T., KULMALA, P., SAVOLA, K., et al. (2000). Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. J. Clin. Endocrinol. Metab. 85, 1126-1132.
14. KULMALA, P., SAVOLA, K., PETERSEN, J.S., et al. (1998). Prediction of insulin-dependent diabetes mellitus in sibling of children with diabetes. A population-based study. J. Clin. Invest 101, 327-336.
15. MOUGIN, B., GARNERO, P., BOREL, O., et al. (2001). A routine assay for the direct analysis of HLA-DR-related shared epitope and B27 alleles in chronic inflammatory arthritis. J. Immunol. Method. 256, 47-53.
16. REWERS, M., BUGAWAN, T.L., NORRIS, J.M., et al. (1996). New-born screening for HLA markers associated with IDDM: Diabetes autoimmunity study in the young (DAISY). Diabetologia 39, 807-812.
17. SCHENKER, M., HUMMEL, M., FERBER, K., et al. (1999). Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type 1 diabetes: the German BABYDIAB study. Diabetologia 42, 671-677.
18. THORSBY, E., and RONNINGEN, K.S. (1993). Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 371-377.
19. TODD, J.A. (1995). Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl. Acad. Sci. USA 92, 8560-8566.
20. UNDLIEN, D.E., FRIEDE, T., RAMMENSEE, H.G., et al. (1997). HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 46, 143-149.
21. VAN DER AUWERA, B., VAN WAEYENBERGER, C., SCHUIT, F., et al. (1995a). DRB*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Belgian Diabetes registry. Diabetes 44, 527-530.
22. VAN DER AUWERA, B., SCHUIT, F., LYARUU, I., et al. (1995b). Genetic Susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ and insulin gene-linked risk. J. Clin. Endocrinol. Metab. 80, 2567-2573.
23. VERGE, C.F., GIANANI, R., KAWASAKI, E., et al. (1996). Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA2 autoantibodies. Diabetes 45, 926-933.